 SOMERSET, N.J.--BUSINESS WIRE--Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that it will release financial results for the third quarter of fiscal year 2022 ended March 31, 2022, before the market open on Tuesday, May 3, 2022. The Companys management will host a webcast to discuss the results at 8:15 a.m. ET o 